Toward imaging of alpha-synuclein with PET.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37541192.
- Also identified by DOI 10.1016/j.cell.2023.06.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Development of radiopharmaceuticals for in vivo positron emission tomography imaging of alpha-synuclein aggregates has the potential to revolutionize Lewy body disease diagnosis and treatment. Reporting in this issue of Cell, Xiang et al. developed a high-affinity positron emission tomography tracer for alpha-synuclein.
Medical subject headings
- alpha-Synuclein
- Positron-Emission Tomography